Literature DB >> 8142142

Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients.

E Fenouillet1, N Blanes, A Coutellier, J C Gluckman.   

Abstract

We studied the influence of HIV p24 antigen immune complexing with anti-p24 antibodies on the assessment of their respective levels in HIV-positive sera. ELISAs were used to evaluate anti-p24 antibody levels and p24 antigenemia, with or without acid dissociation. Observations include the following: (1) p24 antigenemia usually coexisted with low anti-p24 levels; (2) the p24 antigen concentration inversely correlated with anti-p24 antibody levels; and (3) acid dissociation increased the percentage of p24 antigen-positive sera, mostly when anti-p24 was low. In contrast, (1) antigenemia and antibodies varied independently in antiretroviral-treated AIDS patients, undetectable p24 antigen coexisting then with low anti-p24; (2) after acid dissociation, antigen was still undetectable in 83% of sera with high antibody levels, and in 20% with low antibody levels; and (3) acid dissociation did not increase low anti-p24 levels. Whereas the first set of observations indicates that p24 antigen and anti-p24 antibodies can be engaged in immune complexes, the second set indicates that p24 antigen and antibodies were not inevitably linked in such complexes: they may actually be indicative of two distinct biological phenomena.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8142142     DOI: 10.1089/aid.1993.9.1251

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.

Authors:  Amy W Chung; Jenniffer M Mabuka; Bongiwe Ndlovu; Anna Licht; Hannah Robinson; Yathisha Ramlakhan; Musie Ghebremichael; Tarylee Reddy; Philip J R Goulder; Bruce D Walker; Thumbi Ndung'u; Galit Alter
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

2.  Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.

Authors:  J M Binley; P J Klasse; Y Cao; I Jones; M Markowitz; D D Ho; J P Moore
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity.

Authors:  E Fenouillet; N Blanes; A Benjouad; J C Gluckman
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

4.  Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection.

Authors:  Caroline Passaes; Héloïse M Delagreverie; Véronique Avettand-Fenoel; Annie David; Valérie Monceaux; Asma Essat; Michaela Müller-Trutwin; Darragh Duffy; Nathalie De Castro; Linda Wittkop; Christine Rouzioux; Jean-Michel Molina; Laurence Meyer; Constance Delaugerre; Asier Sáez-Cirión
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.